ArticleFoot & ankle international2026
Motion-Preserving Salvage for Failed Total Ankle Arthroplasty or Talar AVN: Outcomes of Combined Total Ankle Arthroplasty with Custom 3D-Printed Total Talus Replacement.
Article in Foot & ankle international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTalar component collapse following total ankle arthroplasty (TAA) and talar avascular necrosis (AVN) with concurrent ankle arthritis represent challenging clinical scenarios. Traditional salvage with tibiotalocalcaneal arthrodesis sacrifices motion and has nonunion rates approaching 30%. This study evaluates outcomes of a motion-preserving salvage strategy: combined TAA with custom 3D-printed total talus replacement (TAA-TTR).
methodsWe retrospectively reviewed consecutive patients who underwent TAA-TTR between September 2020 and December 2023. Indications included talar component collapse following prior TAA or talar AVN with ankle and subtalar arthritis. Subtalar arthrodesis was performed using 2 screws with use of bone marrow aspirate concentrate. Primary endpoint was complication rate; secondary endpoints included reoperations, radiographic assessments, and functional recovery milestones.
resultsEighteen patients (10 females, 8 males; mean age 57.8 ± 10.8 years) were analyzed at mean follow-up of 36.8 ± 16.6 months, after excluding 2 with <12 months' follow-up. Nine had talar AVN and 9 had failed TAA. The complication rate was 33.3% (95% CI: 15.2%-57.3%) (AVN group 44%, revision TAA group 22%). Six patients experienced complications: superficial surgical site infection (SSI) (1), deep SSI requiring debridement surgery (2), extensor hallucis longus rupture (1), nerve-related complication (1), and asymptomatic Chopart joint subluxation (1). Two patients required serial operations, including 1 below-knee amputation for persistent pain and infection. Reoperation rate was 11.1% (95% CI: 3.1%-32.8%). Patients achieved rapid functional recovery: controlled ankle motion boot transition at mean 19.9 days, full weight-bearing at mean 46.9 days, and regular footwear at mean 10.7 weeks. All patients achieved radiographic osseointegration of talar component to the calcaneus.
conclusionTAA-TTR represents a viable motion-preserving procedure in this challenging population. Although patients achieved relatively rapid functional recovery and transition to regular footwear, rigorous selection remains key. This approach demonstrates a manageable complication rate while addressing tibiotalar and subtalar pathology simultaneously. LEVEL OF EVIDENCE: Level IV, retrospective case series.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.